![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, October 02, 2014 11:38:38 PM
I does it mean personal but we all know that the shareprices of every upcoming biotech company falls or goes up depending on the announcements they make. So far nothing new here.
What will it be?
Gerald has told us many times already that Lympro will be on the Market next year. I think the man is trustworthy. Why? I can't imagine he puts his good reputation at stake at this very early stage of truth for AMBS right now.
Gerald is trying to run the business independently as long as possible. That's also good for us.
I expect good numbers and at what time exactly Lympro will be in the Market,is not so important, in my believe. Not too late I hope.
Good numbers gives AMBS the possibility to generate income and to stay longer independant at least for the upcoming two years and is of course good for the shareprice.
I's all a question of believing or disbelieving, that's biotechland.
What do we think it will be? More reactions please.
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM
POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • POET • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM